|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
ABSTRACT |
|---|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Eosinophilic bronchitis presents with chronic cough and sputum eosinophilia, but without the abnormalities of airway function seen in asthma. It is important to know how commonly eosinophilic bronchitis causes cough, since in contrast to cough in patients without sputum eosinophilia, the cough responds to inhaled corticosteroids. We investigated patients referred over a 2-yr period with chronic cough, using a well-established protocol with the addition of induced sputum in selected cases. Eosinophilic bronchitis was diagnosed if patients had no symptoms suggesting variable airflow obstruction, and had normal spirometric values, normal peak expiratory flow variability, no airway hyperresponsiveness (provocative concentration of methacholine producing a 20% decrease in FEV1 ([PC20] > 8 mg/ml), and sputum eosinophilia (> 3%). Ninety-one patients with chronic cough were identified among 856 referrals. The primary diagnosis was eosinophilic bronchitis in 12 patients, rhinitis in 20, asthma in 16, post-viral-infection status in 12, and gastroesophageal reflux in seven. In a further 18 patients a diagnosis was established. The cause of chronic cough remained unexplained in six patients. In all 12 patients with eosinophilic bronchitis, the cough improved after treatment with inhaled budesonide 400 µg twice daily, and in eight of these patients who had a follow-up sputum analysis, the eosinophil count decreased significantly, from 16.8% to 1.6%. We conclude that eosinophilic bronchitis is a common cause of chronic cough, and that sputum induction is important in the investigation of cough.
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Gibson and colleagues (1, 2) have described a group of patients with corticosteroid-responsive chronic cough who had sputum evidence of an eosinophilic bronchitis but normal spirometry, no evidence of airway hyperresponsiveness (AHR), and normal peak expiratory flow (PEF) variability. The features of this condition were distinct from those of asthma, and Gibson and colleagues suggested that it should be known as eosinophilic bronchitis. It is important to know how commonly eosinophilic bronchitis causes chronic cough, since in contrast to cough in patients without sputum eosinophilia (3), the cough responds well to inhaled corticosteroids (2). Current algorithms for investigating chronic cough do not include assessment of airway inflammation, and would not allow recognition of these patients.
We have modified a well-validated protocol (4, 5) for investigating chronic cough by adding a differential inflammatory cell count on induced sputum if a diagnosis has not been reached after a history, clinical examination, chest radiography, spirometry, serial measurement of PEF, and a methacholine inhalation test. We used this modified protocol to prospectively look for evidence of eosinophilic bronchitis in new patients with chronic cough of more than 3 wk duration who were seen by a single consultant between January 1996 to December 1997.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Subjects
Patients with an isolated chronic cough lasting more than 3 wk were identified from new patient referrals made between January 1996 and December 1997 to a single respiratory physician by primary care physicians in both rural and urban areas. Patients were between 28 and 76 yr of age, and other than having a chronic cough, had no clinical or radiologic evidence of significant lung disease at the time of referral. Subjects gave full informed consent to participate in the study. The protocol was approved by the Leicestershire Health Authority ethics committee.
Measurements
Spirometry was done with a rolling-seal spirometer (Vitalograph, Buckingham, UK), with recording of the greater of successive readings within a 200 ml range. If the FEV1/FVC ratio was < 70%, spirometry was repeated 15 min after inhalation of 200 µg salbutamol. Allergen skin sensitivity was measured by skin prick testing with Dermatophagoides pteronyssinus, cat fur, grass pollen, and Aspergillus fumigatus solutions, with controls consisting of normal saline and histamine (Bencard, Brentford, UK). PEF was measured twice daily as the best of three expirations, using a mini-Wright peak flow meter (Clement Clarke Ltd., London, UK). Airway responsiveness was measured according to the tidal breathing method (6). Sputum was induced and processed as suggested by Pizzichini and colleagues (7). Briefly, sputum was induced with 3%, 4%, and 5% saline inhaled in sequence for 5 min via an ultrasonic nebulizer (Medix, Harlow, UK; output: 0.9 ml/ min; mass median aerodynamic diameter: 5.5 µm). After each inhalation, patients blew their noses and rinsed their mouths to minimize nasal contamination, and expectorated sputum into a sterile pot. FEV1 was measured after each inhalation, and subjects were pretreated with inhaled salbutamol in a dose of 200 µg at 10 min before sputum induction in order to minimize bronchoconstriction. Sputum free of salivary contamination was selected and was mixed with four times its volume of 0.1% dithiothreitol. Mixing was achieved by shaking with a vortex machine for 15 s, gentle aspiration in and out of a Pasteur pipette, and rocking on a bench rocker for 15 min. The sample was further diluted with an equal amount of phosphate-buffered saline (PBS), before being filtered through a 48-µm-mesh gauze and centrifuged at 2,000 rpm (790 × g) for 10 min. The cell pellet was resuspended in PBS. A total cell count was taken and cell viability was assessed with a Neubauer hemocytometer and the trypan blue exclusion method. The cell suspension was readjusted to 1 × 106 cells/ml, and 75 µl was suspended in cytocentrifuge cups and centrifuged at 450 rpm (18 × g) for 6 min. After air drying, the cytospin preparation was stained with Romanowski's stain and a differential cell count was obtained by counting > 400 nonsquamous cells.
Protocol
The cause of chronic cough in each subject was investigated according to the anatomic-diagnostic protocol suggested by Irwin and colleagues (4, 5), with modifications similar to those suggested by O'Connell and coworkers (8) (Table 1, Figure 1). All patients had an initial clinical assessment consisting of a history, physical examination, chest radiograph, allergen skin prick tests, twice-daily measurement of peak expiratory flow for at least 2 wk, and, if appropriate, spirometry with reversibility studies following inhalation of 200 µg of salbutamol (Figure 1). A trial of treatment was begun only if patients had one or more symptoms suggesting an underlying diagnosis, together with at least one positive finding on examination or investigation. The clinical features and abnormalities found in the study, and the investigations and therapies used, are outlined on Table 1. Patients were followed up after 6 to 8 wk and asked if their cough had improved. The primary diagnosis was accepted if pretreatment criteria were fulfilled and the cough improved with specific therapy. In situations in which more than one disease process was thought to be contributing to the cough, therapy aimed at all potential causes was begun and the most important cause in the opinion of the responsible clinician was designated the primary diagnosis. If no initial cause for the cough could be identified, or if the initial treatment did not alleviate the cough, the patient had a methacholine inhalation test followed by sputum induction. Other investigations were dictated by the individual clinical picture (Table 1, Figure 1). Eosinophilic bronchitis was diagnosed if a patient had a cough, no symptoms suggesting variable airflow obstruction, normal spirometric values, normal peak PEF variability (percent difference of the maximum within-day amplitude of < 20% from the mean over a 2-wk period [9]), a provocative concentration of methacholine causing a 20% decrease in FEV1 (PC20) > 8 mg/ml, and sputum eosinophilia of > 3% nonsquamous cells. We chose 3% in order to be consistent with Carney and colleagues' (10) definition of eosinophilic bronchitis, and because this is > 3SD outside the normal range in our laboratory (our normal range is 0 to 1%).
|
|
Analysis
Methacholine PC20 was calculated by linear interpolation of the log dose-response curve. The sputum eosinophil count was not normally distributed, and was log transformed and described as a geometric mean. Changes in sputum eosinophil count were expressed as -fold differences with a 95% confidence interval (CI).
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Ninety-one patients with chronic cough were identified from 856 new referrals seen between January 1996 and December 1997 (10.6%). A diagnosis leading to successful treatment was reached in 93% of cases. Fifty-one (56%) patients had findings at presentation suggestive of a primary diagnosis, which was successfully treated in 44 (48%) patients. Four of the remaining seven patients, and the 40 (44%) patients who did not have suggestive clinical features, had a methacholine challenge and sputum induction. This led to a diagnosis in a further 20 patients. The remaining 27 patients had further investigations, resulting in a diagnosis in 21 cases, and thus leaving six (7%) patients with unexplained cough (Figure 1). Ten patients (11%) were thought to have more than one explanation for their cough. In seven patients gastroesophageal reflux was one of the codiagnoses. Sputum suitable for processing was obtained from 40 of the 44 patients who had sputum induction. Of the four patients in whom sputum induction was unsuccessful, two had AHR and were diagnosed as having asthma. The other two patients had no explanation for their cough. All of the patients with unexplained cough had empirical treatment directed toward asthma, eosinophilic bronchitis, rhinitis, and gastroesophageal reflux, without clinical improvement in any case.
The causes of cough are shown in Table 2. Eosinophilic bronchitis was the primary diagnosis for cough in 12 (13.2%) patients. The characteristics of these patients are shown in Table 3. After treatment with budesonide 400 µg given via a turbohaler, cough improved in all 12 patients. In eight patients repeat sputum induction was performed from 4 to 8 wk after treatment was begun, and showed a significant decrease in the sputum eosinophil count, from a geometric mean of 16.8% to 1.6% (10.7-fold difference; 95% CI: 4.1 to 27.7; p < 0.01).
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
We successfully identified a cause or causes for chronic cough in most patients, confirming the diagnostic value of the anatomic-diagnostic approach suggested by Irwin and colleagues (4). Our treatment success rate of 93% was very similar to those reported by Irwin and colleagues (4, 5) and others (11) in a similar patient population, and was slightly higher than that reported by O'Connell and coworkers (8) and McGarvey and associates (12) in patients referred to a tertiary referral center. We have confirmed that rhinitis and gastroesophageal reflux are common causes of chronic cough in this clinical setting. Our modified protocol allowed us to recognize eosinophilic bronchitis in 13% of patients. This estimate of the incidence of eosinophilic bronchitis is similar to that reported by Carney and associates (10), who used diagnostic criteria identical to ours and found three cases in 30 patients with chronic cough.
Our data and those of Carney and associates suggest that assessment of airway inflammation is an important addition to the algorithm for investigating chronic cough. We chose to assess airway inflammation with induced sputum, since this method is noninvasive and has been shown to be successful in the majority of patients with asthma (13). Sputum differential cell counts have been shown to be valid and repeatable in patients with asthma (7). We have shown that sputum induction is also successful in most patients with chronic cough, and that sputum eosinophilia is the only significant finding in 13% of cases of such cough. Although we chose to analyze induced sputum, spontaneous sputum could be used if patients have a productive cough. Differential cell counts are similar with the two methods, but the cell viability is greater and squamous cell contamination less with induced sputum, resulting in better quality cytospin preparations (14).
The patients with eosinophilic bronchitis in our study presented with a cough without wheezing, dyspnea, or objective evidence of variable airflow obstruction, and thus did not meet conventional criteria for the diagnosis of asthma (13). They had a subjective improvement in their cough and a significant decrease in their sputum eosinophil count after treatment with inhaled corticosteroids, which resembled the findings of Gibson and coworkers (3). We did not formally assess the time course of the response to corticosteroids, although anecdotally, improvement began 2 to 3 wk after inhaled corticosteroids were begun.
Most previous studies have not identified patients with eosinophilic bronchitis as a distinct subgroup among patients with chronic cough. Although one cannot discount the possibility that eosinophilic bronchitis is a new condition, we feel that the failure to recognize it in previous studies is more likely to reflect differences in referral pattern, or less stringent criteria for the diagnosis of asthma. Many patients, particularly tertiary referrals, are likely to have received a trial of corticosteroids before referral, and those patients who responded to corticosteroids may have been diagnosed as having asthma before further tests were done or irrespective of the results of objective tests of variable airflow obstruction or airway responsiveness. We diagnosed asthma in patients with consistent symptoms and objective evidence of variable airflow obstruction and/or AHR. Our criteria for an objective demonstration of variable airflow obstruction and AHR are widely accepted (6, 9, 15), and particularly in the case of methacholine inhalation testing are sensitive markers of currently symptomatic asthma. In common with previous reports, our diagnosis of asthma was subjectively supported by successful response to treatment (12, 16). It has been proposed that a negative histamine or methacholine challenge rules out asthma and therefore obviates the need for a trial of inhaled steroids (12). We agree that normal airway responsiveness makes a diagnosis of asthma very unlikely, but disagree that this precludes the need for a trial of inhaled corticosteroids, since this approach would deny effective treatment to a significant number of patients.
Typically, the patients with eosinophilic bronchitis in our study presented in middle age with a dry cough or a cough productive of small amounts of viscid sputum in the morning. Few were smokers, perhaps reflecting a selection bias, since primary-care physicians are likely to attribute a chronic cough in smokers to chronic bronchitis, and would therefore not refer these patients for a specialist's opinion. Four of our patients with eosinophilic bronchitis had symptoms of rhinitis, although the absence of other clinical or radiographic features and lack of improvement in cough following treatment of rhinitis by their primary-care physicians lead us to perform further investigations and to conclude that eosinophilic bronchitis was the primary cause of cough in these patients. We have not studied the natural history of this condition, but the long duration of symptoms before referral suggests that it is a chronic problem.
The recognition of patients with sputum eosinophilia without variable airflow obstruction (eosinophilic bronchitis) has important implications for understanding the role of airway inflammation in asthma, and suggests that in some cases, the conventional view of a direct relationship between eosinophilic airway inflammation and AHR (17) is overly simplistic. Possible explanations for the relative absence of a functional effect of eosinophilic airway inflammation in our patients include differences in the site or state of activation of the inflammatory response. An alternative possibility is that AHR is increased by the airway inflammation in eosinophilic bronchitis, but stays within the normal range because baseline airway responsiveness is far to the right of the normal range. We have recently observed such a phenomenon in a patient with eosinophilic bronchitis studied during an exacerbation of eosinophilic airway inflammation (18). Further research is required into the cause of and relationship between airway inflammation, AHR, and cough in patients with eosinophilic bronchitis.
We conclude that eosinophilic bronchitis is a common cause of chronic cough in patients referred for a specialist's opinion. Recognition of patients with a cough caused by eosinophilic bronchitis is important, since effective treatment is possible. We suggest that assessment of airway inflammation be added as an important component of the investigation of cough.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. I. D. Pavord, Consultant Physician, Department of Respiratory Medicine, Glenfield Hospital, Groby Rd, Leicester LE3 9QP, UK.
(Received in original form October 28, 1998 and in revised form January 4, 1999).
Acknowledgments: The authors thank the staff of the Respiratory Physiology Department, Glenfield Hospital, for help with the sputum inductions, and the Department of Histopathology for help with sputum processing.
Supported by a grant from Glenfield Hospital Local Research Committee and Astra Charnwood, Loughborough, UK.
| |
References |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1. Gibson, P. G., J. Dolovich, J. Denburg, E. H. Ramsdale, and F. E. Hargreave. 1989. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1: 1346-1348 [Medline].
2. Gibson, P. G., F. E. Hargreave, A. Girgis-Gabardo, M. Morris, J. A. Denburg, and J. Dolovich. 1995. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin. Exp. Allergy 25: 127-132 [Medline].
3. Pizzichini, E., M. M. M. Pizzichini, K. Parameswaran, and F. E. Hargreave. 1998. Budesonide Turbuhaler in non-asthmatic non-eosinophilic chronic cough (abstract). Am. J. Respir. Crit. Care Med. 157: A836 .
4. Irwin, R. S., W. M. Corrao, and M. R. Pratter. 1981. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am. Rev. Respir. Dis. 123: 413-417 [Medline].
5. Irwin, R. S., F. J. Curley, and C. L. French. 1990. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am. Rev. Respir. Dis. 141: 640-647 [Medline].
6. Juniper, E. F., D. W. Cockcroft, and F. E. Hargreave. 1994. Histamine and Methacholine Inhalation Tests: A Laboratory Tidal Breathing Protocol, 2nd ed. Astra Draco AB, Lund, Sweden.
7. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am. J. Respir. Crit. Care Med. 154: 308-317 [Abstract].
8. O'Connell, F., V. E. Thomas, N. B. Pride, and R. W. Fuller. 1994. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am. J. Respir. Crit. Care Med. 150: 374-380 [Abstract].
9. Jamison, J. P., and R. K. McKinley. 1993. Validity of peak expiratory flow rate variability for the diagnosis of asthma. Clin. Sci. 85: 367-371 [Medline].
10.
Carney, I. K.,
P. G. Gibson,
K. Murnee-Allen,
N. Saltos,
L. G. Olsen, and
M. J. Hensley.
1997.
A systematic evaluation of mechanisms in
chronic cough.
Am. J. Respir. Crit. Care Med.
156:
211-216
11.
Poe, R. H.,
R. V. Harder,
R. H. Israel, and
M. C. Kallay.
1989.
Chronic
persistent cough: experience in diagnosis and outcome using an anatomic diagnostic protocol.
Chest
95:
723-728
12.
McGarvey, L. P.,
L. G. Heaney,
J. T. Lawson,
B. T. Johnston,
C. M. Scally,
M. Ennis,
D. R. Shepherd, and
J. MacMahon.
1998.
Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol.
Thorax
53:
738-743
13. Hunter, C. J., R. Ward, G. Woltmann, A. J. Wardlaw, and I. D. Pavord. 1999. The safety and success rate of sputum induction using a low output ultrasonic nebuliser. Respir. Med. 93: 345-348 [Medline].
14. Pizzichini, M. M., T. A. Popov, A. Efthimiadis, P. Hussack, S. Evans, E. Pizzichini, J. Dolovich, and F. E. Hargreave. 1996. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154: 866-869 [Abstract].
15.
Taylor, D. R..
1997.
Making the diagnosis of asthma.
B.M.J.
315:
4-5
16.
Irwin, R. S.,
C. T. French,
N. A. Smyrnios, and
F. J. Curley.
1997.
Interpretation of positive results of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
Arch. Intern. Med.
157:
1981-1987
17. Barnes, P. J.. 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J. Allergy Clin. Immunol. 83: 1013-1026 [Medline].
18. Wong, A. G., I. D. Pavord, M. R. Sears, and F. E. Hargreave. 1996. A case for serial examination of sputum inflammatory cells. Eur. Respir. J. 9: 2174-2175 [Abstract].
This article has been cited by other articles:
 |
|
 |
|
  C. Barber and D Fishwick Chronic cough - occupational considerations Chronic Respiratory Disease, November 1, 2008; 5(4): 211 - 221. [Abstract] [PDF]
|
|
|
|
 |
|
 M.-J. Oh, J.-Y. Lee, B.-J. Lee, and D.-C. Choi Exhaled Nitric Oxide Measurement Is Useful for the Exclusion of Nonasthmatic Eosinophilic Bronchitis in Patients With Chronic Cough Chest, November 1, 2008; 134(5): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rytila, L. Ghaly, S. Varghese, W. Chung, O. Selroos, T. Haahtela, and on behalf of the Airway Inflammation Study group Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function Eur. Respir. J., October 1, 2008; 32(4): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Woodman, S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-{beta}1 J. Immunol., October 1, 2008; 181(7): 5001 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hollins, D. Kaur, W. Yang, G. Cruse, R. Saunders, A. Sutcliffe, P. Berger, A. Ito, C. E. Brightling, and P. Bradding Human Airway Smooth Muscle Promotes Human Lung Mast Cell Survival, Proliferation, and Constitutive Activation: Cooperative Roles for CADM1, Stem Cell Factor, and IL-6 J. Immunol., August 15, 2008; 181(4): 2772 - 2780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Birring, T. Fleming, S. Matos, A. A. Raj, D. H. Evans, and I. D. Pavord The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough Eur. Respir. J., May 1, 2008; 31(5): 1013 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Morice Review Series: Chronic cough: Epidemiology Chronic Respiratory Disease, February 1, 2008; 5(1): 43 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Y. Hahn, T. I. Morgenthaler, and K. G. Lim Use of Exhaled Nitric Oxide in Predicting Response to Inhaled Corticosteroids for Chronic Cough Mayo Clin. Proc., November 1, 2007; 82(11): 1350 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bradding Mast cell regulation of airway smooth muscle function in asthma Eur. Respir. J., May 1, 2007; 29(5): 827 - 830. [Full Text] [PDF]
|
|
|
|
 |
|
 I. D Pavord Non-eosinophilic asthma and the innate immune response Thorax, March 1, 2007; 62(3): 193 - 194. [Full Text] [PDF]
|
|
|
|
|
|
A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu Recommendations for the management of cough in adults Thorax, September 1, 2006; 61(suppl_1): i1 - i24. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Irwin, R. Ownbey, P. T. Cagle, S. Baker, and A. E. Fraire Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study. Chest, August 1, 2006; 130(2): 362 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Woodman, A. Sutcliffe, D. Kaur, M. Berry, P. Bradding, I. D. Pavord, and C. E. Brightling Chemokine Concentrations and Mast Cell Chemotactic Activity in BAL Fluid in Patients With Eosinophilic Bronchitis and Asthma, and in Normal Control Subjects. Chest, August 1, 2006; 130(2): 371 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Clinical Applications of Induced Sputum Chest, May 1, 2006; 129(5): 1344 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Pratter Overview of Common Causes of Chronic Cough: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 59S - 62S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Irwin Chronic Cough Due to Gastroesophageal Reflux Disease: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 80S - 94S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 116S - 121S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Rosen Chronic Cough Due to Bronchiectasis: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 122S - 131S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. B.S. Prakash Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 206S - 219S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Pratter, C. E. Brightling, L. P. Boulet, and R. S. Irwin An Empiric Integrative Approach to the Management of Cough: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 222S - 231S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hargreave and K. Parameswaran Efficacy of fluticasone on cough Eur. Respir. J., July 1, 2005; 26(1): 181 - 181. [Full Text] [PDF]
|
|
|
|
|
|
B. P. Ponsioen, P. N. R. Dekhuijzen, A. M. Bohnen, and N. A. Vermue From the authors Eur. Respir. J., July 1, 2005; 26(1): 181 - 182. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Brightling, A. J. Ammit, D. Kaur, J. L. Black, A. J. Wardlaw, J. M. Hughes, and P. Bradding The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1103 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Haque, O. S. Usmani, and P. J. Barnes Chronic Idiopathic Cough: A Discrete Clinical Entity? Chest, May 1, 2005; 127(5): 1710 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mund, B. Christensson, R. Gronneberg, and K. Larsson Noneosinophilic CD4 Lymphocytic Airway Inflammation in Menopausal Women With Chronic Dry Cough Chest, May 1, 2005; 127(5): 1714 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Brightling, S McKenna, B Hargadon, S Birring, R Green, R Siva, M Berry, D Parker, W Monteiro, I D Pavord, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease Thorax, March 1, 2005; 60(3): 193 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Pavord Chronic cough: a rational approach to investigation and management Eur. Respir. J., February 1, 2005; 25(2): 213 - 215. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Kastelik, I. Aziz, J. C. Ojoo, R. H. Thompson, A. E. Redington, and A. H. Morice Investigation and management of chronic cough using a probability-based algorithm Eur. Respir. J., February 1, 2005; 25(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Prudon, S. S. Birring, D. D. Vara, A. P. Hall, J. P. Thompson, and I. D. Pavord Cough and Glottic-Stop Reflex Sensitivity in Health and Disease Chest, February 1, 2005; 127(2): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.N. Patterson, B.T. Johnston, J. MacMahon, L.G. Heaney, and L.P.A. McGarvey Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough" Eur. Respir. J., November 1, 2004; 24(5): 724 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.H. Morice and committee members The diagnosis and management of chronic cough Eur. Respir. J., September 1, 2004; 24(3): 481 - 492. [Full Text] [PDF]
|
|
|
|
|
|
C E Brightling and I D Pavord Location, location, location: microlocalisation of inflammatory cells and airway dysfunction Thorax, September 1, 2004; 59(9): 734 - 735. [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Park, Y. M. Lee, A. S. Jang, J. H. Lee, Y. Hwangbo, D. J. Kim, and C.-S. Park Development of Chronic Airway Obstruction in Patients With Eosinophilic Bronchitis: A Prospective Follow-up Study Chest, June 1, 2004; 125(6): 1998 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanazawa, S. Nomura, and J. Yoshikawa Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P G Gibson Atopic cough Thorax, May 1, 2004; 59(5): 449 - 449. [Full Text] [PDF]
|
|
|
|
|
|
L P A McGarvey Cough * 6: Which investigations are most useful in the diagnosis of chronic cough? Thorax, April 1, 2004; 59(4): 342 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.S. Birring, C. Passant, R.B. Patel, B. Prudon, G.E. Murty, and I.D. Pavord Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough Eur. Respir. J., February 1, 2004; 23(2): 199 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P V Dicpinigaitis Cough {middle dot} 4: Cough in asthma and eosinophilic bronchitis Thorax, January 1, 2004; 59(1): 71 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Birring, D. Parker, C. E. Brightling, P. Bradding, A. J. Wardlaw, and I. D. Pavord Induced Sputum Inflammatory Mediator Concentrations in Chronic Cough Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 15 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S S Birring, C E Brightling, F A Symon, S G Barlow, A J Wardlaw, and I D Pavord Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis Thorax, December 1, 2003; 58(12): 1066 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A H Morice and J A Kastelik Cough * 1: Chronic cough in adults Thorax, October 1, 2003; 58(10): 901 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J A Kastelik, A E Redington, I Aziz, G K Buckton, C M Smith, M Dakkak, and A H Morice Abnormal oesophageal motility in patients with chronic cough Thorax, August 1, 2003; 58(8): 699 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marchand, B. Etienne-Mastroianni, P. Chanez, D. Lauque, P. Leclerc, J.F. Cordier, and the Groupe d'Etudes et de Recherche sur les Maladi Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur. Respir. J., July 1, 2003; 22(1): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Brightling, F A Symon, S S Birring, P Bradding, A J Wardlaw, and I D Pavord Comparison of airway immunopathology of eosinophilic bronchitis and asthma Thorax, June 1, 2003; 58(6): 528 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S S Birring, B Prudon, A J Carr, S J Singh, M D L Morgan, and I D Pavord Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) Thorax, April 1, 2003; 58(4): 339 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, M. Romagnoli, L. Corbetta, G. Casoni, K. Busljetic, G. Turato, G. Ligabue, A. Ciaccia, M. Saetta, and A. Papi Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 418 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Minoguchi, K Minoguchi, A Tanaka, H Matsuo, N Kihara, and M Adachi Cough receptor sensitivity to capsaicin does not change after allergen bronchoprovocation in allergic asthma Thorax, January 1, 2003; 58(1): 19 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Birring, C. E. Brightling, P. Bradding, J. J. Entwisle, D. D. Vara, J. Grigg, A. J. Wardlaw, and I. D. Pavord Clinical, Radiologic, and Induced Sputum Features of Chronic Obstructive Pulmonary Disease in Nonsmokers: A Descriptive Study Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Leader of the Working Group: E. Pizzichini, Members of the Working Group:, M.M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk Safety of sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 9S - 18s. [Full Text] [PDF]
|
|
|
|
|
|
Leader of the Working Group:, I.D. Pavord, Members of the Working Group:, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, R. Louis, M.M.M. Pizzichini, E.H. Bel, et al. Clinical applications of assessment of airway inflammation using induced sputum Eur. Respir. J., July 1, 2002; 20(37_suppl): 40S - 43s. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Irwin and J. M. Madison The Persistently Troublesome Cough Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1469 - 1474. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Brightling, P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord Mast-Cell Infiltration of Airway Smooth Muscle in Asthma N. Engl. J. Med., May 30, 2002; 346(22): 1699 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Irwin, J. K. Zawacki, M. M. Wilson, C. T. French, and M. P. Callery Chronic Cough due to Gastroesophageal Reflux Disease* : Failure to Resolve Despite Total/Near-Total Elimination of Esophageal Acid Chest, April 1, 2002; 121(4): 1132 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P G Gibson, M Fujimura, and A Niimi Eosinophilic bronchitis: clinical manifestations and implications for treatment Thorax, February 1, 2002; 57(2): 178 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Brightling, F A Symon, S S Birring, A J Wardlaw, R Robinson, and I D Pavord A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet Thorax, January 1, 2002; 57(1): 91 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Lee, J. Y. Cho, J. J. Shim, H. K. Kim, K. H. Kang, S. H. Yoo, and K. H. In Airway Inflammation as an Assessment of Chronic Nonproductive Cough Chest, October 1, 2001; 120(4): 1114 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Irwin and J. M. Madison Symptom Research on Chronic Cough: A Historical Perspective Ann Intern Med, May 1, 2001; 134(9_Part_2): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Irwin and J. M. Madison The Diagnosis and Treatment of Cough N. Engl. J. Med., December 7, 2000; 343(23): 1715 - 1721. [Full Text] [PDF]
|
|
|
|
|
|
C. E. BRIGHTLING, R. WARD, G. WOLTMANN, P. BRADDING, J. R. SHELLER, R. DWORSKI, and I. D. PAVORD Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 878 - 882. [Abstract] [Full Text]
|
|
|
|
|
|
D. W. Cockcroft Eosinophilic Bronchitis as a Cause of Cough Chest, July 1, 2000; 118(1): 277 - 277. [Full Text] [PDF]
|
|
|
|
|
|
L. McGarvey, L. Heaney, J. MacMahon, M. Ennis, M. Fujimura, C. E. Brightling, and J. D. Pavord EOSINOPHILIC BRONCHITIS IS AN IMPORTANT CAUSE OF CHRONIC COUGH Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1764 - 1765. [Full Text] [PDF]
|
|
|
|
 |
|
 Causes of Chronic Cough Journal Watch (General), September 7, 1999; 1999(907): 2 - 2. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |